302 related articles for article (PubMed ID: 24150707)
21. Associations between lutein, zeaxanthin, and age-related macular degeneration: an overview.
Carpentier S; Knaus M; Suh M
Crit Rev Food Sci Nutr; 2009 Apr; 49(4):313-26. PubMed ID: 19234943
[TBL] [Abstract][Full Text] [Related]
22. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative.
Moeller SM; Parekh N; Tinker L; Ritenbaugh C; Blodi B; Wallace RB; Mares JA;
Arch Ophthalmol; 2006 Aug; 124(8):1151-62. PubMed ID: 16908818
[TBL] [Abstract][Full Text] [Related]
23. Lutein and zeaxanthin supplementation reduces H2O2-induced oxidative damage in human lens epithelial cells.
Gao S; Qin T; Liu Z; Caceres MA; Ronchi CF; Chen CY; Yeum KJ; Taylor A; Blumberg JB; Liu Y; Shang F
Mol Vis; 2011; 17():3180-90. PubMed ID: 22194644
[TBL] [Abstract][Full Text] [Related]
24. Lutein and zeaxanthin for macular degeneration.
Zhao L; Sweet BV
Am J Health Syst Pharm; 2008 Jul; 65(13):1232-8. PubMed ID: 18574012
[TBL] [Abstract][Full Text] [Related]
25. Dietary sources of lutein and zeaxanthin carotenoids and their role in eye health.
Abdel-Aal el-SM; Akhtar H; Zaheer K; Ali R
Nutrients; 2013 Apr; 5(4):1169-85. PubMed ID: 23571649
[TBL] [Abstract][Full Text] [Related]
26. Lutein and zeaxanthin and their potential roles in disease prevention.
Ribaya-Mercado JD; Blumberg JB
J Am Coll Nutr; 2004 Dec; 23(6 Suppl):567S-587S. PubMed ID: 15640510
[TBL] [Abstract][Full Text] [Related]
27. The potential role of dietary xanthophylls in cataract and age-related macular degeneration.
Moeller SM; Jacques PF; Blumberg JB
J Am Coll Nutr; 2000 Oct; 19(5 Suppl):522S-527S. PubMed ID: 11023002
[TBL] [Abstract][Full Text] [Related]
28. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
[TBL] [Abstract][Full Text] [Related]
29. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye.
Krinsky NI; Landrum JT; Bone RA
Annu Rev Nutr; 2003; 23():171-201. PubMed ID: 12626691
[TBL] [Abstract][Full Text] [Related]
30. Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up.
Wu J; Cho E; Willett WC; Sastry SM; Schaumberg DA
JAMA Ophthalmol; 2015 Dec; 133(12):1415-24. PubMed ID: 26447482
[TBL] [Abstract][Full Text] [Related]
31. Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration.
Robman L; Vu H; Hodge A; Tikellis G; Dimitrov P; McCarty C; Guymer R
Can J Ophthalmol; 2007 Oct; 42(5):720-6. PubMed ID: 17724493
[TBL] [Abstract][Full Text] [Related]
32. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study.
Delcourt C; Carrière I; Delage M; Barberger-Gateau P; Schalch W;
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2329-35. PubMed ID: 16723441
[TBL] [Abstract][Full Text] [Related]
33. Competitive inhibition of carotenoid transport and tissue concentrations by high dose supplements of lutein, zeaxanthin and beta-carotene.
Wang Y; Roger Illingworth D; Connor SL; Barton Duell P; Connor WE
Eur J Nutr; 2010 Sep; 49(6):327-36. PubMed ID: 20082082
[TBL] [Abstract][Full Text] [Related]
34. Carotenoid intake and risk of non-Hodgkin lymphoma: a systematic review and dose-response meta-analysis of observational studies.
Chen F; Hu J; Liu P; Li J; Wei Z; Liu P
Ann Hematol; 2017 Jun; 96(6):957-965. PubMed ID: 28011986
[TBL] [Abstract][Full Text] [Related]
35. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
[TBL] [Abstract][Full Text] [Related]
36. Prospective study of serum retinol, beta-carotene, beta-cryptoxanthin, and lutein/zeaxanthin and esophageal and gastric cancers in China.
Abnet CC; Qiao YL; Dawsey SM; Buckman DW; Yang CS; Blot WJ; Dong ZW; Taylor PR; Mark SD
Cancer Causes Control; 2003 Sep; 14(7):645-55. PubMed ID: 14575362
[TBL] [Abstract][Full Text] [Related]
37. Intake of lutein and zeaxanthin differ with age, sex, and ethnicity.
Johnson EJ; Maras JE; Rasmussen HM; Tucker KL
J Am Diet Assoc; 2010 Sep; 110(9):1357-62. PubMed ID: 20800129
[TBL] [Abstract][Full Text] [Related]
38. Lutein and zeaxanthin intakes and risk of age-related macular degeneration and cataracts: an evaluation using the Food and Drug Administration's evidence-based review system for health claims.
Trumbo PR; Ellwood KC
Am J Clin Nutr; 2006 Nov; 84(5):971-4. PubMed ID: 17093145
[TBL] [Abstract][Full Text] [Related]
39. Dietary Intake and Circulating Concentrations of Carotenoids and Risk of Type 2 Diabetes: A Dose-Response Meta-Analysis of Prospective Observational Studies.
Jiang YW; Sun ZH; Tong WW; Yang K; Guo KQ; Liu G; Pan A
Adv Nutr; 2021 Oct; 12(5):1723-1733. PubMed ID: 33979433
[TBL] [Abstract][Full Text] [Related]
40. The relationship between antioxidant nutrient intake and cataracts in older people.
Rodríguez-Rodríguez E; Ortega RM; López-Sobaler AM; Aparicio A; Bermejo LM; Marín-Arias LI
Int J Vitam Nutr Res; 2006 Nov; 76(6):359-66. PubMed ID: 17607955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
